Recombinant Protein Drugs Market Report

Global and Region Recombinant Protein Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 03, 2022
  • PAGES：236
  • REPORT CODE：GMM1023377
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Recombinant Protein Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Recombinant Protein Drugsmarket, defines the market attractiveness level of Recombinant Protein Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Recombinant Protein Drugs industry, describes the types of Recombinant Protein Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Recombinant Protein Drugs market and the development prospects and opportunities of Recombinant Protein Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Recombinant Protein Drugs market in Chapter 13.

    By Player:

    • GenSci

    • Amgen

    • Heng Rui

    • Eli Lilly

    • Novo Nordisk

    • Dongbao Pharm

    • Roche

    • Ortho Biotech

    • SL PHARM

    • Kyowa Hakko Kirin

    • Pharmingen

    • NCPC

    • Ankebio

    • Sanofi

    • Abcam

    • Merck Serono

    By Type:

    • Recombinant DNA

    • Recombinant RNA

    By End-User:

    • Pharmaceutical Industry

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Recombinant Protein Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Recombinant Protein Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Recombinant Protein Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Recombinant Protein Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Recombinant Protein Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Recombinant Protein Drugs Consumption (2017-2022)

    • 7.2 United States Recombinant Protein Drugs Consumption (2017-2022)

    • 7.3 Europe Recombinant Protein Drugs Consumption (2017-2022)

    • 7.4 China Recombinant Protein Drugs Consumption (2017-2022)

    • 7.5 Japan Recombinant Protein Drugs Consumption (2017-2022)

    • 7.6 India Recombinant Protein Drugs Consumption (2017-2022)

    • 7.7 South Korea Recombinant Protein Drugs Consumption (2017-2022)

    8 Region and Country-wise Recombinant Protein Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Recombinant Protein Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Recombinant Protein Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Recombinant Protein Drugs Consumption Forecast (2022-2028)

    • 8.4 China Recombinant Protein Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Recombinant Protein Drugs Consumption Forecast (2022-2028)

    • 8.6 India Recombinant Protein Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Recombinant Protein Drugs Consumption Forecast (2022-2028)

    9 Global Recombinant Protein Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Recombinant Protein Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Recombinant DNA Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Recombinant RNA Consumption and Growth Rate (2017-2022)

    • 9.2 Global Recombinant Protein Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmaceutical Industry Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Recombinant Protein Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Recombinant Protein Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Recombinant DNA Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Recombinant RNA Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Recombinant Protein Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Pharmaceutical Industry Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Recombinant Protein Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Recombinant Protein Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Recombinant Protein Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Recombinant Protein Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Recombinant Protein Drugs Market Competitive Analysis

    • 14.1 GenSci

      • 14.1.1 GenSci Company Details

      • 14.1.2 GenSci Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GenSci Recombinant Protein Drugs Product and Service

    • 14.2 Amgen

      • 14.2.1 Amgen Company Details

      • 14.2.2 Amgen Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Amgen Recombinant Protein Drugs Product and Service

    • 14.3 Heng Rui

      • 14.3.1 Heng Rui Company Details

      • 14.3.2 Heng Rui Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Heng Rui Recombinant Protein Drugs Product and Service

    • 14.4 Eli Lilly

      • 14.4.1 Eli Lilly Company Details

      • 14.4.2 Eli Lilly Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eli Lilly Recombinant Protein Drugs Product and Service

    • 14.5 Novo Nordisk

      • 14.5.1 Novo Nordisk Company Details

      • 14.5.2 Novo Nordisk Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Novo Nordisk Recombinant Protein Drugs Product and Service

    • 14.6 Dongbao Pharm

      • 14.6.1 Dongbao Pharm Company Details

      • 14.6.2 Dongbao Pharm Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Dongbao Pharm Recombinant Protein Drugs Product and Service

    • 14.7 Roche

      • 14.7.1 Roche Company Details

      • 14.7.2 Roche Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Roche Recombinant Protein Drugs Product and Service

    • 14.8 Ortho Biotech

      • 14.8.1 Ortho Biotech Company Details

      • 14.8.2 Ortho Biotech Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Ortho Biotech Recombinant Protein Drugs Product and Service

    • 14.9 SL PHARM

      • 14.9.1 SL PHARM Company Details

      • 14.9.2 SL PHARM Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 SL PHARM Recombinant Protein Drugs Product and Service

    • 14.10 Kyowa Hakko Kirin

      • 14.10.1 Kyowa Hakko Kirin Company Details

      • 14.10.2 Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Kyowa Hakko Kirin Recombinant Protein Drugs Product and Service

    • 14.11 Pharmingen

      • 14.11.1 Pharmingen Company Details

      • 14.11.2 Pharmingen Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Pharmingen Recombinant Protein Drugs Product and Service

    • 14.12 NCPC

      • 14.12.1 NCPC Company Details

      • 14.12.2 NCPC Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 NCPC Recombinant Protein Drugs Product and Service

    • 14.13 Ankebio

      • 14.13.1 Ankebio Company Details

      • 14.13.2 Ankebio Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Ankebio Recombinant Protein Drugs Product and Service

    • 14.14 Sanofi

      • 14.14.1 Sanofi Company Details

      • 14.14.2 Sanofi Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Sanofi Recombinant Protein Drugs Product and Service

    • 14.15 Abcam

      • 14.15.1 Abcam Company Details

      • 14.15.2 Abcam Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Abcam Recombinant Protein Drugs Product and Service

    • 14.16 Merck Serono

      • 14.16.1 Merck Serono Company Details

      • 14.16.2 Merck Serono Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Merck Serono Recombinant Protein Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Recombinant Protein Drugs

    • Figure Recombinant Protein Drugs Picture

    • Table Global Recombinant Protein Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Protein Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Recombinant Protein Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Recombinant Protein Drugs Consumption by Country (2017-2022)

    • Figure United States Recombinant Protein Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Recombinant Protein Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Recombinant Protein Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Recombinant Protein Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Recombinant Protein Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Recombinant Protein Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant Protein Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Recombinant Protein Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Recombinant Protein Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Recombinant Protein Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Recombinant Protein Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Recombinant Protein Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Recombinant Protein Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant DNA Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant RNA Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical Industry Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant DNA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant RNA Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical Industry Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Recombinant Protein Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Recombinant Protein Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table GenSci (Foundation Year, Company Profile and etc.)

    • Table GenSci Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GenSci Recombinant Protein Drugs Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Recombinant Protein Drugs Product and Service

    • Table Heng Rui (Foundation Year, Company Profile and etc.)

    • Table Heng Rui Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Heng Rui Recombinant Protein Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Recombinant Protein Drugs Product and Service

    • Table Novo Nordisk (Foundation Year, Company Profile and etc.)

    • Table Novo Nordisk Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novo Nordisk Recombinant Protein Drugs Product and Service

    • Table Dongbao Pharm (Foundation Year, Company Profile and etc.)

    • Table Dongbao Pharm Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dongbao Pharm Recombinant Protein Drugs Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Recombinant Protein Drugs Product and Service

    • Table Ortho Biotech (Foundation Year, Company Profile and etc.)

    • Table Ortho Biotech Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ortho Biotech Recombinant Protein Drugs Product and Service

    • Table SL PHARM (Foundation Year, Company Profile and etc.)

    • Table SL PHARM Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table SL PHARM Recombinant Protein Drugs Product and Service

    • Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)

    • Table Kyowa Hakko Kirin Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kyowa Hakko Kirin Recombinant Protein Drugs Product and Service

    • Table Pharmingen (Foundation Year, Company Profile and etc.)

    • Table Pharmingen Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pharmingen Recombinant Protein Drugs Product and Service

    • Table NCPC (Foundation Year, Company Profile and etc.)

    • Table NCPC Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table NCPC Recombinant Protein Drugs Product and Service

    • Table Ankebio (Foundation Year, Company Profile and etc.)

    • Table Ankebio Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ankebio Recombinant Protein Drugs Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Recombinant Protein Drugs Product and Service

    • Table Abcam (Foundation Year, Company Profile and etc.)

    • Table Abcam Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abcam Recombinant Protein Drugs Product and Service

    • Table Merck Serono (Foundation Year, Company Profile and etc.)

    • Table Merck Serono Recombinant Protein Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Serono Recombinant Protein Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US